Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 10 - 21    tags : Disease    save search

Newly Published Data Continue to Support Long-Term Efficacy of TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED)
Published: 2021-10-21 (Crawled : 19:00) - biospace.com/
HZNP | $116.3 0.03% 29M twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 2.43% C: 2.13%

disease eye eye disease
Cue Biopharma Announces Publication in The Journal of Clinical Investigation Highlighting Immuno-STAT Biologics for the Treatment of Chronic Infectious Diseases
Published: 2021-10-21 (Crawled : 18:00) - biospace.com/
CUE | $1.57 -0.63% -0.64% 170K twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 2.51% C: -0.97%

disease treatment biopharma infectious disease
LogicBio Therapeutics Announces Successful Repopulation of Diseased Livers in Mice with Healthy Corrected Hepatocytes in Two New Indications Using GeneRide™ Genome Editing Technology
Published: 2021-10-21 (Crawled : 13:15) - biospace.com/
LOGC | $2.07 -0.48% twitter stocktwits trandingview |
Health Technology
| | O: 5.2% H: 0.0% C: -8.24%

disease genome editing technology liver
Selecta Biosciences and Genovis Enter Exclusive License Agreement to Advance Next-Generation IgG Protease in Gene Therapy and Autoimmune Disease
Published: 2021-10-21 (Crawled : 13:15) - biospace.com/
SELB 4 | $0.8812 -8.0% 2.12% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 4.37% C: 1.54%

disease gene therapy therapy license
SCYNEXIS Pivotal Phase 3 VANISH-303 Trial Results Published in Clinical Infectious Diseases Demonstrate Significant Superiority of Ibrexafungerp Over Placebo for Treatment of Vaginal Yeast Infection
Published: 2021-10-21 (Crawled : 13:00) - biospace.com/
SCYX | $1.44 2.49% 2.43% 130K twitter stocktwits trandingview |
Health Technology
| | O: 0.95% H: 3.58% C: 2.83%

disease treatment infectious disease results phase 3 trial trial results injection infections
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.